Skip to content
“The COVID-19 pandemic pushed back years of progress made combating antimicrobial resistance (AMR) in the United States,” the Centers for Disease Control and Prevention […]
Combating antimicrobial resistance requires urgent development of new drugs Read More »
A new gene editing method called base editing, which could make gene editing more precise, is being clinically tested for the first time, Good
Base editing makes its clinical trial debut Read More »
In response to the Supreme Court ruling on Dobbs v. Jackson Women’s Health Organization, which overturns the Court’s previous ruling on Roe v. Wade,
The most recent data from the Bureau of Labor Statistics (BLS), which came out last week, shows that drug prices are rising more slowly
BLS: Inflation is way up – but drug prices are not Read More »
The NSIA-LUTH Cancer Center (NLCC) in Lagos, Nigeria was meant to bring big changes for Nigerians, but it wasn’t delivering on its potential, apparently
Building a cancer center around patients in Nigeria Read More »
Thanks to gene therapies, previously untreatable diseases are now treatable and patient quality of life has improved exponentially. Yet, gene therapy regulatory challenges, along
How gene therapy regulatory challenges impact R&D, manufacturing, patients Read More »
In an alarming trend that’s reversed decades of progress and put children’s lives at risk, 25 million children missed one or more doses of
WHO: Childhood vaccinations see largest decline in 3 decades Read More »
COVID lockdowns caused a much shorter flu season than usual, but we’re already seeing record numbers of influenza in Australia and elsewhere in the
As influenza cases rise in Australia, Seqirus prepares for US flu season Read More »
It feels like just yesterday that Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), visited member company Novavax with Maryland
John Trizzino, Executive Vice President, Chief Commercial Officer, and Chief Business Officer of Novavax, joined Good Day BIO Live at the BIO International Convention,
Vaccine in 100 days ‘extraordinarily possible,’ says John Trizzino of Novavax Read More »
